Crispr Therapeutics shares owned by Capital Research and Management Company - Division 3
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Research and Management Company - Division 3
from 13F filings
Historical chart of Capital Research and Management Company - Division 3 investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital Research and Management Company - Division 3 consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital Research and Management Company - Division 3
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $366M | 5.6M | 64.81 |
| 2025-06-30 | $272M | 5.6M | 48.64 |
| 2025-03-31 | $207M | 6.1M | 34.03 |
| 2024-12-31 | $344M | 8.7M | 39.36 |
| 2024-09-30 | $372M | 7.9M | 46.98 |
| 2024-03-31 | $534M | 7.8M | 68.16 |
| 2023-12-31 | $384M | 6.1M | 62.60 |
| 2023-09-30 | $276M | 6.1M | 45.39 |
| 2023-06-30 | $341M | 6.1M | 56.14 |
| 2023-03-31 | $272M | 6.0M | 45.23 |
| 2022-12-31 | $218M | 5.4M | 40.65 |
| 2022-03-31 | $226M | 3.6M | 62.77 |
| 2021-12-31 | $272M | 3.6M | 75.78 |
| 2021-09-30 | $468M | 4.2M | 111.93 |
| 2021-06-30 | $743M | 4.6M | 161.87 |
| 2021-03-31 | $593M | 4.9M | 121.84 |
| 2020-12-31 | $1.1B | 7.4M | 153.12 |
| 2020-09-30 | $619M | 7.4M | 83.64 |
| 2020-06-30 | $41M | 553k | 73.49 |
| 2020-03-31 | $24M | 553k | 42.41 |
| 2019-12-31 | $23M | 375k | 60.90 |
| 2019-09-30 | $5.7M | 138k | 40.99 |
| 2019-06-30 | $6.5M | 138k | 47.10 |
| 2019-03-31 | $4.9M | 138k | 35.72 |
| 2018-12-31 | $3.9M | 138k | 28.57 |
| 2018-09-30 | $6.1M | 138k | 44.35 |
More positions owned by Capital Research and Management Company - Division 3
View all positions for Capital Research and Management Company - Division 3